Amylin Pharmaceuticals

company

About

Amylin Pharmaceuticals is a biopharmaceutical company, engages in the discovery, development, and commercialization of drugs.

  • 5001 - 10000

Details

Last Funding Type
Series Unknown
Industries
Biotechnology
Founded date
Jan 1, 1987
Number Of Employee
5001 - 10000
Operating Status
Active

Amylin Pharmaceuticals is a biopharmaceutical company, engages in the discovery, development, and commercialization of drugs.

Develops a line of diagnostic and therapeutic products for diabetics.

Working towards a cure for diabetes by challenging science, changing lives. Amylin employees are dedicated in their ability to "think outside the box". Because of our commitment of constantly finding newer and better ways to treat diabetes, we come to work each day feeling like we CAN make a difference in our world.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
1
Amylin Pharmaceuticals has raised a total of — in funding over 2 rounds. Their latest funding was raised on Jan 1, 1990 from a Series Unknown round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Jan 1, 1990 Series Unknown 1 Detail

Investors

Number of Lead Investors
Number of Investors
1
Amylin Pharmaceuticals is funded by 1 investors. Sequoia Capital are the most recent investors.
Investor Name Lead Investor Funding Round
Sequoia Capital Series Unknown